Pavmed Series Z Stock Alpha and Beta Analysis
| PAVMZ Stock | USD 0.01 0.0001 0.66% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as PAVmed Series Z. It also helps investors analyze the systematic and unsystematic risks associated with investing in PAVmed Series over a specified time horizon. Remember, high PAVmed Series' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to PAVmed Series' market risk premium analysis include:
Beta (7.52) | Alpha 10.94 | Risk 195.12 | Sharpe Ratio 0.27 | Expected Return 52.21 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
PAVmed |
PAVmed Series Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. PAVmed Series market risk premium is the additional return an investor will receive from holding PAVmed Series long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in PAVmed Series. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate PAVmed Series' performance over market.| α | 10.94 | β | -7.52 |
PAVmed Series Fundamentals Vs Peers
Comparing PAVmed Series' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze PAVmed Series' direct or indirect competition across all of the common fundamentals between PAVmed Series and the related equities. This way, we can detect undervalued stocks with similar characteristics as PAVmed Series or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of PAVmed Series' fundamental indicators could also be used in its relative valuation, which is a method of valuing PAVmed Series by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare PAVmed Series to competition |
| Fundamentals | PAVmed Series | Peer Average |
| Return On Equity | -13.58 | -0.31 |
| Return On Asset | -0.8 | -0.14 |
| Operating Margin | (13.98) % | (5.51) % |
| Number Of Shares Shorted | 46.01 K | 4.71 M |
| Revenue | 2.45 M | 9.43 B |
| EBITDA | (75.74 M) | 3.9 B |
| Net Income | (64.17 M) | 570.98 M |
PAVmed Series Opportunities
PAVmed Series Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors - The Globe and Mail | 06/06/2024 |
2 | PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024 - StockTitan | 10/31/2024 |
About PAVmed Series Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including PAVmed or other stocks. Alpha measures the amount that position in PAVmed Series Z has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2023 | 2024 (projected) | Dividend Yield | 3.31E-4 | 2.98E-4 | 2.65E-4 | Price To Sales Ratio | 381.38 | 12.15 | 11.54 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PAVmed Series in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PAVmed Series' short interest history, or implied volatility extrapolated from PAVmed Series options trading.
Build Portfolio with PAVmed Series
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for PAVmed Stock Analysis
When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.